Prescriby Secures $2 Million in Pre-Seed Funding to Revolutionize Addictive Medication Treatment Management

We are thrilled to announce that Prescriby has successfully raised $2,000,000 in funding to fuel our mission of revolutionizing the management of addictive medications. As the first data-driven treatment management platform, Prescriby aims to address the critical issue of addiction by leveraging innovative technology to support healthcare professionals in their prescribing practices. With addictive medications like opioids and benzodiazepines posing a significant risk for chronic use and addiction, our platform provides clinics with a safe corridor to manage these complex prescriptions more effectively. This funding will allow us to enhance our technology, improve our healthcare toolkit, and expand our reach to clinics nationwide. By streamlining the prescribing process, we not only save valuable time for healthcare providers but also prioritize patient safety and reduce the likelihood of substance abuse. We believe that by integrating advanced data analytics into treatment management, we can create a win-win solution that empowers clinicians and protects patients alike. We invite you to follow us on this transformative journey as we work to lead the digital transition in addictive medication treatment management. Stay tuned for updates on our progress and how we are shaping the future of healthcare in this critical area!